155 related articles for article (PubMed ID: 7351267)
1. Circulating immune complexes in systemic scleroderma and generalized morphea.
O'Loughlin S; Tappeiner G; Jordon RE
Dermatologica; 1980; 160(1):25-30. PubMed ID: 7351267
[TBL] [Abstract][Full Text] [Related]
2. [Circulating immune complexes in progressive systemic scleroderma and morphea].
Yotsumoto H; Shimokawa Y; Hisadome H; Tashiro M
Nihon Hifuka Gakkai Zasshi; 1983 May; 93(6):579-83. PubMed ID: 6620628
[No Abstract] [Full Text] [Related]
3. Antihistone antibodies in scleroderma.
Parodi A; Drosera M; Barbieri L; Rebora A
Dermatology; 1995; 191(1):16-8. PubMed ID: 8589476
[TBL] [Abstract][Full Text] [Related]
4. Antinuclear antibodies in localized scleroderma.
Takehara K; Moroi Y; Nakabayashi Y; Ishibashi Y
Arthritis Rheum; 1983 May; 26(5):612-6. PubMed ID: 6405756
[TBL] [Abstract][Full Text] [Related]
5. Anticentromere antibody in localized scleroderma.
Ruffatti A; Peserico A; Glorioso S; Fiocco U; Rossi L; Gambari P; Todesco S
J Am Acad Dermatol; 1986 Oct; 15(4 Pt 1):637-42. PubMed ID: 3534010
[TBL] [Abstract][Full Text] [Related]
6. Localized and systemic scleroderma.
Hawk A; English JC
Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
[TBL] [Abstract][Full Text] [Related]
7. Circulating Fc gamma receptor-specific autoantibodies in localized and systemic scleroderma.
Davis K; Boros P; Keltz M; Unkeless JC; Fleischmajer R
J Am Acad Dermatol; 1995 Oct; 33(4):612-6. PubMed ID: 7673494
[TBL] [Abstract][Full Text] [Related]
8. Anti-phosphatidylserine-prothrombin complex antibodies in patients with localized scleroderma.
Hasegawa M; Fujimoto M; Hayakawa I; Matsushita T; Nishijima C; Yamazaki M; Takehara K; Sato S
Clin Exp Rheumatol; 2006; 24(1):19-24. PubMed ID: 16539814
[TBL] [Abstract][Full Text] [Related]
9. Association of HLA antigens with progressive systemic sclerosis and morphea.
Kühnl P; Sibrowski W; Boehm BO; Holzmann H; Sollberg S
Tissue Antigens; 1989 Sep; 34(3):207-9. PubMed ID: 2595726
[TBL] [Abstract][Full Text] [Related]
10. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
[TBL] [Abstract][Full Text] [Related]
11. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea.
Falanga V; Medsger TA; Reichlin M
Arch Dermatol; 1987 Mar; 123(3):350-3. PubMed ID: 3545090
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of morphea and systemic sclerosis.
Soma Y; Tamaki T; Kikuchi K; Abe M; Igarashi A; Takehara K; Ishibashi Y
Dermatology; 1993; 186(2):103-5. PubMed ID: 8428037
[TBL] [Abstract][Full Text] [Related]
13. Guttate morphea in a scleroderma spectrum disorder patient with anticentromere antibody.
Yamanaka M; Ishikawa O
Eur J Dermatol; 2009; 19(6):630-1. PubMed ID: 19596641
[No Abstract] [Full Text] [Related]
14. [Scleroderma with special reference to generalized morphea].
Tanioku K; Fukushiro S
Nihon Rinsho; 1973 Dec; 31(12):3394-401. PubMed ID: 4799679
[No Abstract] [Full Text] [Related]
15. Elevated levels of antibodies to polyuridylic acid detected and quantitated in systemic scleroderma patients by solid phase radioimmunoassay.
Heinzerling RH; Weyer R; Dziuba DS; Belviso HM; Burnham TK
J Invest Dermatol; 1980 Sep; 75(3):224-7. PubMed ID: 6157754
[TBL] [Abstract][Full Text] [Related]
16. Localized scleroderma progressing to systemic disease. Case report and review of the literature.
Birdi N; Laxer RM; Thorner P; Fritzler MJ; Silverman ED
Arthritis Rheum; 1993 Mar; 36(3):410-5. PubMed ID: 8452586
[TBL] [Abstract][Full Text] [Related]
17. [HLA antigen frequencies in patients with progressive systemic sclerosis and morphea (author's transl)].
Freudenberg J; Holzmann H; Schneider S; Korting GW
Arch Dermatol Res; 1978 Nov; 263(2):197-205. PubMed ID: 736604
[TBL] [Abstract][Full Text] [Related]
18. [Scleroderma].
Scharffetter K; Kind P; Wollny-Protzel D; Schuppe HC; Lakomek HJ; Goerz G
Z Hautkr; 1990 Mar; 65(3):237-42, 245-6. PubMed ID: 2187309
[TBL] [Abstract][Full Text] [Related]
19. The presence of dominant T-cell clones in peripheral blood of patients with collagen vascular disorders: a prospective study of 97 cases.
Dereure O; Gubler B; Bessis D; Guillot B; Guilhou JJ; Clot J; Eliaou JF
Br J Dermatol; 2006 Mar; 154(3):445-9. PubMed ID: 16445773
[TBL] [Abstract][Full Text] [Related]
20. [The immune status of scleroderma patients undergoing electroacupuncture].
Glavinskaia TA; Rezaĭkina AV; Smirnova AV
Vestn Dermatol Venerol; 1989; (4):44-7. PubMed ID: 2788340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
